EPIVA is a smart infusion pump that modulates the amount of epidural analgesia administered based on patient demand through a patented algorithm. The EPIVA algorithm intuitively controls and adjusts the background dose of epidural analgesia by reviewing the patients demand history. This is coupled with a robust pump mechanism which effectively injects analgesic boluses at high pressures into the epidural space. EPIVA has been clinically validated to reduce the incidence of breakthrough pain and clinician intervention through providing personalized pain relief for every birth.
EPIVA is currently undergoing the worlds largest clinical trial in epidural analgesia. Please see link for more information. By 2016, EPIVA pump is set to obtain CE marking by the European Union.
Innovfusion was founded in 2013 in Singapore, based on novel pain management technology developed at, and licensed from, KK Womens and Childrens Hospital, a leading maternity hospital in Southeast Asia. As an incubatee of The Biofactory, Innovfusion was able to accelerate the development and launch of smart infusion pumps for pain management during labour.
Our mission is to incorporate smart algorithms into world-class sensing technologies to develop high-quality infusion pump systems that support personalized and safe pain management. We share the common vision to make intuitive drug infusion systems a reality, improving patient safety, and cutting costs for hospitals through reducing physician manpower requirements.
Since 2015, Innovfusion has moved to a new purpose-built ISO13485 manufacturing and production facility at Block 79, JTC LaunchPad.